Japan's Otsuka to Acquire U.S. Firm Astex for $886M

Source: PharmaManufacturing.com

Sep 05, 2013

Reuters

Japanese drugmaker Otsuka Holdings Co. has agreed to buy Astex Pharmaceuticals Inc. for about $886 million to tap cancer drugs under development by the U.S. biotechnology company. Read the full story
Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments